InvestorsHub Logo
Followers 54
Posts 1832
Boards Moderated 0
Alias Born 03/22/2015

Re: The ELTP King post# 339118

Monday, 07/20/2020 8:44:56 PM

Monday, July 20, 2020 8:44:56 PM

Post# of 413958

Did you ever see the results of Nasrat's hard work "over the next six to twelve months" from July 7, 2017?

I didn't.






You bet I did!



https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=86154&GoTopage=1&Category=2163&BzID=2258&t=2086&G=939

Sep 20, 2017
Elite Pharmaceuticals Files ANDA For Oxycodone Hydrochloride Extended Release
NORTHVALE, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) --

...

"I am very pleased with this filing of an ANDA for a generic version of OxyContin®. This is our fourth ANDA filing in the past 15 months and is a key addition to our portfolio," said Nasrat Hakim, President and CEO of Elite. "Elite is committed to developing a diverse range of opioid abuse-deterrent pain products and attractive niche generics."





https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=88209&GoTopage=2&Category=2163&BzID=2258&t=2180&G=939

Aug 06, 2018
Elite Pharmaceuticals Receives FDA Approval For Generic Methadone Hydrochloride Tablets
NORTHVALE, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) --

...

"I am pleased to receive FDA approval for our methadone ANDA filing. We expect methadone to be a key product for our marketing alliance with Glenmark Pharmaceuticals," stated Nasrat Hakim, President and CEO of Elite.






Occam's razor: the simplest solution is most likely the right one.

Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News